QuidelOrtho Corp (QDEL)
37.89
+0.41
(+1.09%)
USD |
NASDAQ |
Nov 21, 16:00
37.91
+0.02
(+0.05%)
Pre-Market: 20:00
QuidelOrtho Enterprise Value: 4.955B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 4.955B |
| November 20, 2024 | 4.927B |
| November 19, 2024 | 5.001B |
| November 18, 2024 | 4.921B |
| November 15, 2024 | 4.840B |
| November 14, 2024 | 5.027B |
| November 13, 2024 | 5.098B |
| November 12, 2024 | 5.174B |
| November 11, 2024 | 5.297B |
| November 08, 2024 | 5.349B |
| November 07, 2024 | 5.020B |
| November 06, 2024 | 5.094B |
| November 05, 2024 | 5.065B |
| November 04, 2024 | 5.036B |
| November 01, 2024 | 5.036B |
| October 31, 2024 | 4.966B |
| October 30, 2024 | 5.029B |
| October 29, 2024 | 4.987B |
| October 28, 2024 | 5.011B |
| October 25, 2024 | 5.007B |
| October 24, 2024 | 5.015B |
| October 23, 2024 | 5.021B |
| October 22, 2024 | 5.073B |
| October 21, 2024 | 5.085B |
| October 18, 2024 | 5.152B |
| Date | Value |
|---|---|
| October 17, 2024 | 5.101B |
| October 16, 2024 | 5.095B |
| October 15, 2024 | 5.110B |
| October 14, 2024 | 5.129B |
| October 11, 2024 | 5.167B |
| October 10, 2024 | 5.229B |
| October 09, 2024 | 5.280B |
| October 08, 2024 | 5.241B |
| October 07, 2024 | 5.337B |
| October 04, 2024 | 5.350B |
| October 03, 2024 | 5.328B |
| October 02, 2024 | 5.395B |
| October 01, 2024 | 5.379B |
| September 30, 2024 | 5.473B |
| September 27, 2024 | 5.519B |
| September 26, 2024 | 5.427B |
| September 25, 2024 | 5.372B |
| September 24, 2024 | 5.508B |
| September 23, 2024 | 5.465B |
| September 20, 2024 | 5.509B |
| September 19, 2024 | 5.565B |
| September 18, 2024 | 5.565B |
| September 17, 2024 | 5.573B |
| September 16, 2024 | 5.549B |
| September 13, 2024 | 5.514B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.407B
Minimum
May 11 2022
12.63B
Maximum
Aug 05 2020
6.254B
Average
5.777B
Median
Nov 19 2021
Enterprise Value Benchmarks
| Abbott Laboratories | 210.81B |
| Becton Dickinson & Co | 83.11B |
| Repligen Corp | 7.680B |
| Perspective Therapeutics Inc | -63.40M |
| Xtant Medical Holdings Inc | 85.83M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.90M |
| Revenue (Quarterly) | 727.10M |
| Total Expenses (Quarterly) | 675.30M |
| EPS Diluted (Quarterly) | -0.30 |
| Gross Profit Margin (Quarterly) | 48.45% |
| Profit Margin (Quarterly) | -2.74% |
| Earnings Yield | -73.63% |
| Operating Earnings Yield | 3.96% |
| Normalized Earnings Yield | -3.500 |